Hypermobility syndrome

M13_HYPERMOBILITY

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M35.7 Cause of death: ICD-10 — M35.7 2 out of 7 registries used, show all original rules.	2212
4. Check minimum number of events None	2212
5. Include endpoints None	2212
6. Filter based on genotype QC (FinnGen only)	2212

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M35
Name in latin: Syndroma hypermobilitatis

NAME	M13_HYPERMOBILITY
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M357
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M357
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypermobility syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12843	11010	1784
Only index persons	12485	10796	1689
Unadjusted period prevalence (%)
Whole population	0.28	0.32	0.05
Only index persons	0.35	0.40	0.06
Median age at first event (years)
Whole population	34.47	36.00	25.00
Only index persons	34.85	36.20	26.18

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2212	2062	150
Unadjusted period prevalence (%)	0.66	0.70	0.07
Median age at first event (years)	38.20	38.22	37.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1916: Matched controls
19158

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M35.7

ICD-10 Finland

Hypermobility syndrome

4503599627370496.0

323.0

1914

M25.5

ICD-10 Finland

Pain in joint

4.8

215.2

1052

3892

M79.7

ICD-10 Finland

Fibromyalgia

12.2

176.9

339

331

N06AX21

ATC

duloxetine; oral

6.0

173.8

551

1200

N03AX16

ATC

pregabalin; oral

4.6

170.3

744

2312

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

139.1

167.4

177

M79.0

ICD-10 Finland

Rheumatism, unspecified

11.8

159.6

310

308

M54.5

ICD-10 Finland

Low back pain

3.6

145.1

1006

4532

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.1

134.9

362

612

N03AX12

ATC

gabapentin; oral

4.6

129.8

525

1443

N02AX02

ATC

tramadol; systemic, rectal

3.3

125.4

959

4489

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

5.8

112.1

348

701

H02AB06

ATC

prednisolone; systemic

2.9

107.8

1068

5754

M01AH05

ATC

etoricoxib; oral

2.9

103.4

1343

8502

M54.4

ICD-10 Finland

Lumbago with sciatica

3.6

101.6

552

1922

P01BA02

ATC

hydroxychloroquine; oral

5.7

99.0

313

639

M79.6

ICD-10 Finland

Pain in limb

2.9

98.5

910

4592

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

5.6

94.2

302

624

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.7

91.3

1063

6077

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.6

90.3

348

878

A02BC02

ATC

pantoprazole; systemic

2.7

89.1

1319

8612

M79.1

ICD-10 Finland

Myalgia

3.6

86.9

468

1589

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

86.6

989

5523

M01AH01

ATC

celecoxib; oral (coxibs)

3.6

86.3

462

1562

N06AA09

ATC

amitriptyline; systemic

4.7

83.2

311

756

R4120

NOMESCO Finland

Occupational therapy

5.8

81.8

248

475

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.3

81.0

141

106

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

78.8

79.9

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

4.5

78.2

307

781

R51.80

ICD-10 Finland

Headache

3.0

76.8

534

2163

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.7

76.4

381

1203

M03BC01

ATC

orphenadrine (citrate); systemic

2.7

74.2

693

3360

M01AC06

ATC

meloxicam; systemic, rectal

2.5

72.6

795

4205

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.7

70.2

641

3048

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.0

70.1

317

915

M03BX02

ATC

tizanidine; oral

2.5

70.1

1387

9872

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

68.3

593

2728

R4110

NOMESCO Finland

Physiotherapy

2.7

67.5

580

2650

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.4

67.4

380

1310

A07EC01

ATC

sulfasalazine; oral, rectal

4.2

67.2

279

743

N06AX16

ATC

venlafaxine; oral

2.9

67.2

479

1948

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

8.2

66.8

156

206

L28

ICPC

Limited function/disability (L)

3.8

66.4

319

967

R03AC02

ATC

salbutamol; inhalant

2.3

65.6

1213

8197

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.3

65.5

376

1312

M01AE02

ATC

naproxen; oral, rectal

2.3

64.8

1315

9263

G44.2

ICD-10 Finland

Tension-type headache

3.0

64.4

451

1805

N02BE01

ATC

paracetamol; systemic, rectal

3.0

62.0

1701

13890

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.1

59.6

377

1401

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.8

59.2

273

794

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

57.4

451

1923

R06.0

ICD-10 Finland

Dyspnoea

2.6

56.9

502

2291

A02BC05

ATC

esomeprazole; systemic

2.2

56.6

850

5074

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

56.2

428

1788

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

152.1

56.2

L03

ICPC

Low back symptom/complaint

2.4

54.9

615

3179

M01AB05

ATC

diclofenac; systemic, rectal

2.2

54.5

1346

9927

M70.6

ICD-10 Finland

Trochanteric bursitis

3.3

53.9

306

1046

A01

ICPC

Pain general/multiple sites

4.1

53.3

228

618

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.2

52.6

215

559

UJF32

NOMESCO Finland

Coloscopy

2.6

52.5

472

2163

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

51.0

359

1418

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

50.0

519

2558

M13.9

ICD-10 Finland

Arthritis, unspecified

4.0

49.9

216

590

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.5

49.7

258

821

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

11.6

49.1

M54.6

ICD-10 Finland

Pain in thoracic spine

3.6

49.0

245

757

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

48.6

807

4928

M54.2

ICD-10 Finland

Cervicalgia

3.7

48.4

233

697

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

47.9

673

3815

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

47.8

325

1251

N06AX11

ATC

mirtazapine; oral

2.2

47.7

700

4044

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

47.4

682

3906

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.2

47.3

192

494

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

46.8

719

4230

K07.60

ICD-10 Finland

Snapping jaw

3.7

46.7

224

668

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

46.6

478

2329

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.6

46.6

409

1835

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

46.3

269

929

G54.0

ICD-10 Finland

Brachial plexus disorders

5.5

45.5

142

277

J01AA02

ATC

doxycycline; systemic

2.1

45.2

1479

11727

R42

ICD-10 Finland

Dizziness and giddiness

2.5

44.8

424

1973

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.9

44.5

197

548

R52.2

ICD-10 Finland

Other chronic pain

5.7

44.4

134

251

Z50.1

ICD-10 Finland

Other physical therapy

4.7

43.9

158

361

L17

ICPC

Foot/toe symptom/complaint

2.3

43.4

517

2693

SPAT1229

SPAT

Assessment of need for aid

4.4

43.0

164

397

C07AB07

ATC

bisoprolol; oral

2.1

42.3

610

3457

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

42.1

540

2909

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

7.1

41.7

105

155

R53

ICD-10 Finland

Malaise and fatigue

2.3

41.2

468

2375

A02BA02

ATC

ranitidine; systemic

2.5

40.7

359

1602

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

40.6

459

2324

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.3

40.6

442

2196

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

40.6

410

1964

R06AE07

ATC

cetirizine; oral

1.9

40.4

1025

7202

C07AA05

ATC

propranolol; systemic

2.2

40.1

509

2717

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.5

40.0

199

608

R52.9

ICD-10 Finland

Pain, unspecified

3.2

39.9

225

757

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.2

39.9

129

262

G43.9

ICD-10 Finland

Migraine, unspecified

3.0

39.7

258

958

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.7

39.6

312

1305

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.1

39.4

163

426

Z31.5

ICD-10 Finland

Genetic counselling

3.3

39.2

215

709

N05AH04

ATC

quetiapine; oral

2.3

39.2

435

2179

R03DC03

ATC

montelukast; oral

2.3

39.1

429

2136

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.4

38.8

367

1696

A02BC01

ATC

omeprazole; systemic

2.1

38.7

521

2844

A02BC03

ATC

lansoprazole; oral

2.1

38.4

529

2917

M02AA07

ATC

piroxicam; topical

2.0

38.1

639

3820

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

38.0

623

3687

M01AX17

ATC

nimesulide; oral

2.3

37.8

416

2070

N02AA05

ATC

oxycodone; systemic

3.2

37.8

218

744

R20.2

ICD-10 Finland

Paraesthesia of skin

3.2

37.5

217

742

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

37.5

184

556

Z71.8

ICD-10 Finland

Other specified counselling

2.0

37.4

589

3427

H02AB07

ATC

prednisone; oral

2.7

37.3

292

1213

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.9

37.1

255

978

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

37.1

647

3918

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

37.0

703

4397

P01AB01

ATC

metronidazole; oral, rectal

1.9

36.6

871

5902

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.3

36.5

416

2101

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

36.1

855

5772

N05BA04

ATC

oxazepam; oral

2.0

36.1

554

3182

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

5.0

36.1

121

256

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

35.8

268

1082

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

4.2

35.7

141

352

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.4

35.7

137

333

N03AX09

ATC

lamotrigine; oral

3.4

35.6

186

590

J01FA10

ATC

azithromycin; systemic

1.9

35.5

1332

10498

M45

ICD-10 Finland

Ankylosing spondylitis

6.4

35.3

154

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

35.1

711

4529

N06AB04

ATC

citalopram; systemic

2.1

34.8

485

2668

ZX140

NOMESCO Finland

Intra articular

13.1

34.4

M50.3

ICD-10 Finland

Other cervical disc degeneration

6.6

34.4

144

ZXA00

NOMESCO Finland

Right side

2.2

34.4

431

2264

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.0

34.1

217

790

L88

ICPC

Rheumatoid/seropositive arthritis

4.6

33.7

121

275

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.7

33.6

249

998

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

4.6

33.5

120

272

L15

ICPC

Knee symptom/complaint

2.2

33.2

410

2135

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

33.1

327

1535

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

33.0

215

793

M47.82

ICD-10 Finland

Other spondylosis, cervical region

5.1

32.9

108

223

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.0

32.8

207

749

M01AH02

ATC

rofecoxib; oral

2.8

32.7

225

859

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.2

32.6

151

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.8

32.6

113

248

K30

ICD-10 Finland

Functional dyspepsia

2.6

32.5

270

1154

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.9

32.5

110

235

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

32.2

378

1922

L02

ICPC

Back symptom/complaint

2.6

32.2

263

1114

N06AA10

ATC

nortriptyline; systemic

5.9

32.1

162

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

31.7

417

2229

L08

ICPC

Shoulder symptom/complaint

2.2

31.4

351

1741

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.6

31.3

254

1070

L01

ICPC

Neck symptom/complaint

2.2

31.1

349

1733

XA402

NOMESCO Finland

ENMG

5.4

31.1

185

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.1

31.1

183

632

L20

ICPC

Joint symptom/complaint NOS

4.2

30.8

123

310

J01FA06

ATC

roxithromycin; oral

1.8

30.8

794

5422

R01AD09

ATC

mometasone; nasal

1.8

30.8

1008

7426

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

30.6

435

2397

ZX120

NOMESCO Finland

Intravenous

2.9

29.9

198

738

M01AB08

ATC

etodolac; oral

3.1

29.6

178

621

M53.2

ICD-10 Finland

Spinal instabilities

12.6

29.6

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.6

29.3

236

990

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

28.7

1100

8416

C01CA24

ATC

epinephrine; parenteral

2.7

28.4

206

812

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

28.4

278

1292

R03BA05

ATC

fluticasone; inhalant

2.0

28.3

425

2383

L16

ICPC

Ankle symptom/complaint

2.4

28.2

256

1143

N06AB10

ATC

escitalopram; oral

1.9

28.1

528

3219

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

6.0

28.1

136

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

27.8

367

1952

G47.3

ICD-10 Finland

Sleep apnoea

2.2

27.8

331

1684

N05BA01

ATC

diazepam; systemic, rectal

2.4

27.7

256

1153

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

27.6

435

2481

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.2

27.6

108

268

N06AB03

ATC

fluoxetine; oral

2.3

27.5

293

1417

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

5.2

27.3

170

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.0

27.3

170

607

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

27.3

155

521

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

27.2

379

2060

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

27.1

272

1277

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

26.9

215

893

L13

ICPC

Hip symptom/complaint

2.4

26.9

261

1204

M01AX05

ATC

glucosamine; oral

2.4

26.8

248

1116

J01FF01

ATC

clindamycin; systemic

1.9

26.8

505

3072

F34.1

ICD-10 Finland

Dysthymia

3.7

26.8

122

346

M24.2

ICD-10 Finland

Disorder of ligament

5.9

26.6

134

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

26.6

341

1790

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

26.5

1480

12520

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

26.4

146

482

ZXA05

NOMESCO Finland

Left side

2.0

26.3

377

2068

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.6

26.3

123

357

M22.4

ICD-10 Finland

Chondromalacia patellae

3.7

26.2

121

347

L12

ICPC

Hand/finger symptom/complaint

2.1

26.2

320

1643

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.7

26.1

197

792

N04BC05

ATC

pramipexole; oral

3.4

26.0

132

408

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.7

25.9

119

340

M54.8

ICD-10 Finland

Other dorsalgia

3.4

25.9

130

399

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.9

25.9

167

611

R02

ICPC

Shortness of breath/dyspnoea

2.4

25.7

235

1050

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

25.6

201

827

M35.3

ICD-10 Finland

Polymyalgia rheumatica

12.4

25.6

M54.3

ICD-10 Finland

Sciatica

3.1

25.5

148

505

L99

ICPC

Musculoskeletal disease other

6.5

25.5

106

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

6.8

25.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

25.1

277

1357

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

25.1

192

779

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

+∞

25.0

N06AX12

ATC

bupropion; oral

2.5

25.0

207

879

N05CF01

ATC

zopiclone; oral

1.8

24.9

508

3159

M47.9

ICD-10 Finland

Spondylosis, unspecified

5.4

24.5

144

T78.4

ICD-10 Finland

Allergy, unspecified

3.0

24.5

151

537

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.1

24.5

140

473

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.4

24.4

123

379

WZC30

NOMESCO Finland

Teaching

2.3

24.3

234

1071

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

6.1

24.3

113

XF404

NOMESCO Finland

Ambulatory ECG

2.9

24.3

154

557

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.1

24.2

138

465

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

6.3

24.2

106

R03BA02

ATC

budesonide; inhalant

2.0

24.1

378

2139

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

24.1

287

1451

M54.1

ICD-10 Finland

Radiculopathy

3.9

24.1

103

277

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

24.0

285

1440

WX110

NOMESCO Finland

Local anesthesy

1.7

23.9

1395

11712

G43.3

ICD-10 Finland

Complicated migraine

4.2

23.9

225

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

23.8

214

948

R03AC03

ATC

terbutaline; inhalant

2.0

23.7

326

1752

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.3

23.7

240

1126

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.4

23.7

208

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

7.0

23.6

C09CA06

ATC

candesartan; oral

2.0

23.6

367

2070

M01AX01

ATC

nabumetone; oral

4.1

23.5

233

M01AB55

ATC

diclofenac, combinations; oral

3.3

23.5

122

384

J01FA09

ATC

clarithromycin; systemic

1.7

23.4

675

4659

B01AB05

ATC

enoxaparin; parenteral

1.8

23.4

456

2788

J01DA01

ATC

[U] cefalexin; systemic

1.6

23.3

1194

9629

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

23.1

433

2606

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

23.0

782

5649

SPAT1240

SPAT

Therapeutic discussion

2.0

22.9

326

1773

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

22.8

230

1077

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

22.8

416

2480

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.4

22.7

212

956

J02AC01

ATC

fluconazole; systemic

1.6

22.7

982

7551

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.2

22.6

123

401

G50.1

ICD-10 Finland

Atypical facial pain

5.5

22.6

128

M54

ICD-10 Finland

Dorsalgia

2.1

22.5

266

1340

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

6.2

22.5

101

N06AB06

ATC

sertraline; oral

2.1

22.5

286

1486

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

22.5

259

1290

S18

ICPC

Laceration/cut

1.7

22.4

640

4391

M43.1

ICD-10 Finland

Spondylolisthesis

3.9

22.3

255

M25.2

ICD-10 Finland

Flail joint

6.0

22.3

106

L29

ICPC

Musculoskeletal sympt/complt other

2.7

22.2

161

630

N03AX11

ATC

topiramate; oral

3.6

22.1

103

298

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

22.1

1013

7881

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

22.1

297

1580

XKD00

NOMESCO Finland

Uroflowmetry

3.3

22.0

113

353

TEA00

NOMESCO Finland

Biopsy of lip

12.0

22.0

XQ800

NOMESCO Finland

Prick test

2.2

21.9

233

1120

A04

ICPC

Weakness/tiredness general

2.1

21.8

281

1466

L04AB04

ATC

adalimumab; parenteral

4.6

21.8

169

WX002

NOMESCO Finland

Sedation and analgesia

2.0

21.8

319

1754

L04AA13

ATC

leflunomide; oral

4.5

21.7

183

R96

ICPC

Asthma

2.4

21.7

187

810

UKC02

NOMESCO Finland

Cystoscopy

2.5

21.6

175

734

M48.0

ICD-10 Finland

Spinal stenosis

2.8

21.4

139

512

L04AX01

ATC

azathioprine; systemic

3.4

21.4

106

323

J01DB01

ATC

cefalexin; oral

1.8

21.3

1564

13727

R11

ICD-10 Finland

Nausea and vomiting

2.5

21.3

181

777

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

7.1

21.2

R50.9

ICD-10 Finland

Fever, unspecified

2.1

21.1

256

1301

J45

ICD-10 Finland

Asthma

2.2

21.1

227

1094

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

4.0

21.0

223

R06AX22

ATC

ebastine; oral

1.8

20.8

400

2419

N03AE01

ATC

clonazepam; systemic

2.9

20.8

134

490

J01MA02

ATC

ciprofloxacin; systemic

1.7

20.7

588

4012

X58

ICD-10 Finland

Exposure to other specified factors

2.0

20.7

279

1484

H02AB04

ATC

methylprednisolone; systemic

2.1

20.6

267

1395

R03BA01

ATC

beclometasone; inhalant

2.0

20.6

279

1485

N06AX22

ATC

agomelatine; oral

4.0

20.6

217

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

20.5

268

1404

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

20.5

289

1559

R52.1

ICD-10 Finland

Chronic intractable pain

7.7

20.4

A06AD11

ATC

lactulose; oral

2.4

20.2

180

792

M79.8

ICD-10 Finland

Other specified soft tissue disorders

13.2

20.2

R05

ICPC

Cough

1.8

20.1

448

2837

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.2

20.1

108

349

A28

ICPC

Limited function/disability NOS

2.7

20.1

146

574

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.4

20.1

174

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.4

20.1

100

306

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.7

20.0

146

577

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

6.1

19.9

G93.3

ICD-10 Finland

Postviral fatigue syndrome

10.2

19.9

L86

ICPC

Back syndrome with radiating pain

3.0

19.9

121

427

R51.81

ICD-10 Finland

Facial pain NOS

4.3

19.9

176

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.4

19.9

178

786

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.4

19.8

293

R06AX27

ATC

desloratadine; oral

1.6

19.8

652

4614

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

19.8

150

604

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

19.7

323

1845

3007

Kela drug reimbursment

Erenumab and fremanezumab

5.1

19.7

128

R01AD05

ATC

budesonide; nasal

2.4

19.6

178

789

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

19.5

221

1090

C03CA01

ATC

furosemide; systemic

2.1

19.4

231

1161

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

19.4

1079

8681

R07.3

ICD-10 Finland

Other chest pain

2.5

19.3

163

696

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

5.4

19.3

110

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.3

19.3

189

871

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

19.3

1087

8766

AA1AD

NOMESCO Finland

CT of head and brain

1.9

19.2

300

1684

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

19.2

130

491

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

19.2

799

5990

WZA10

NOMESCO Finland

Long statement of health and health related matters

6.1

19.1

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

5.0

19.1

128

R00.2

ICD-10 Finland

Palpitations

2.4

19.1

176

788

D07AD01

ATC

clobetasol; topical

2.0

19.1

282

1548

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.5

19.1

162

695

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.9

19.1

291

1617

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.2

18.9

103

337

R5599

NOMESCO Finland

Other rehabilitation service

4.1

18.9

190

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

18.8

255

1354

R51

ICD-10 Finland

Headache

2.5

18.7

156

662

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.0

18.7

113

397

XA800

NOMESCO Finland

Neuropsychological investigation

3.2

18.6

100

324

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

4.0

18.5

198

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

7.4

18.5

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

18.5

502

3360

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

18.4

128

489

J01EA01

ATC

trimethoprim; systemic

1.7

18.4

527

3581

A02BC04

ATC

rabeprazole; oral

2.3

18.3

185

864

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.2

18.2

100

329

Z01.2

ICD-10 Finland

Dental examination

1.5

18.2

878

6785

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

18.2

1022

8182

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.4

18.2

158

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

18.2

175

800

H03AA01

ATC

levothyroxine sodium; systemic

1.7

18.2

462

3030

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

18.1

392

2452

Z00.0

ICD-10 Finland

General medical examination

1.8

18.0

346

2085

R01AD08

ATC

fluticasone; nasal

1.6

18.0

597

4213

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

18.0

165

735

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

17.8

177

820

G43

ICD-10 Finland

Migraine

2.3

17.8

174

799

UJF92

NOMESCO Finland

Capsular endoscopy

4.5

17.7

144

Z01.9

ICD-10 Finland

Special examination, unspecified

2.8

17.7

117

436

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.9

17.6

107

377

R01AD12

ATC

fluticasone furoate; nasal

1.6

17.6

686

5031

SPAT1216

SPAT

Assessment of functional ability

2.1

17.5

199

983

K02.1

ICD-10 Finland

Caries of dentine

1.5

17.5

1178

9789

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

17.5

330

1973

WZA90

NOMESCO Finland

Other doctors statement

1.7

17.5

466

3096

M53.8

ICD-10 Finland

Other specified dorsopathies

9.2

17.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

17.4

817

6254

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.6

17.3

226

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

17.3

183

873

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.4

17.3

R1250

NOMESCO Finland

Evaluation of functional capability

4.6

17.2

134

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.0

17.2

M05BA04

ATC

alendronic acid; oral

3.2

17.1

293

D01

ICPC

Abdominal pain/cramps general

1.9

17.1

258

1426

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

17.1

105

373

K59.1

ICD-10 Finland

Functional diarrhoea

2.9

17.1

108

390

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.1

17.1

326

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

17.0

705

5235

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

17.0

154

684

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.7

16.9

123

483

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

16.9

133

546

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

16.9

571

4031

R05

ICD-10 Finland

Cough

1.8

16.9

339

2067

G44.0

ICD-10 Finland

Cluster headache syndrome

5.4

16.8

L04AB01

ATC

etanercept; parenteral

4.6

16.8

129

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

16.7

170

796

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

16.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

16.7

199

1001

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

6.1

16.7

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.4

16.7

244

M01AH03

ATC

valdecoxib; oral

2.7

16.6

118

459

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.0

16.6

340

M22.0

ICD-10 Finland

Recurrent dislocation of patella

4.5

16.6

135

F45.0

ICD-10 Finland

Somatization disorder

11.7

16.5

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

4.4

16.4

141

ZXH09

SPAT

3.6

16.3

216

M89.0

ICD-10 Finland

Algoneurodystrophy

6.5

16.3

M03BX01

ATC

baclofen; systemic

4.6

16.3

124

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.2

16.1

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

16.0

119

475

N02CC07

ATC

frovatriptan; oral

2.3

16.0

153

696

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

15.9

576

4123

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.5

15.9

127

C08DA01

ATC

verapamil; systemic

3.5

15.9

216

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.7

15.8

111

429

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.8

15.8

102

375

P03

ICPC

Feeling depressed

1.9

15.8

265

1520

P01

ICPC

Feeling anxious/nervous/tense

1.8

15.8

326

2000

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.3

15.7

138

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

5.2

15.6

UJD02

NOMESCO Finland

Gastroscopy

3.1

15.6

285

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

15.5

678

5067

G43.8

ICD-10 Finland

Other migraine

3.8

15.5

179

N02CC03

ATC

zolmitriptan; nasal, oral

2.2

15.4

166

798

R06.5

ICD-10 Finland

Mouth breathing

2.4

15.4

138

606

M41.9

ICD-10 Finland

Scoliosis, unspecified

6.6

15.4

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.8

15.4

109

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.2

15.3

167

806

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

15.1

129

556

N06AX03

ATC

mianserin; oral

2.9

15.1

325

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

15.0

443

3006

E0000UV

ATC

1.5

15.0

752

5782

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.5

15.0

122

513

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.7

14.9

185

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.0

14.9

150

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

7.0

14.9

XG466

NOMESCO Finland

Sleep oxymetry

4.2

14.9

136

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.2

14.9

136

L11

ICPC

Wrist symptom/complaint

2.1

14.9

186

954

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

14.8

523

3710

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

14.8

1349

11738

N02AJ13

ATC

tramadol and paracetamol; systemic

4.5

14.7

119

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

6.0

14.7

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

6.0

14.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

14.6

443

3025

C07AB02

ATC

metoprolol; systemic

1.9

14.6

218

1199

R03BA08

ATC

ciclesonide; inhalant

2.1

14.6

176

891

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

14.6

164

803

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.6

14.5

105

413

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

14.5

122

523

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.2

14.5

135

SPAT1325

SPAT

Vaccination

1.6

14.4

520

3702

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

14.3

186

967

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.0

14.3

146

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

14.3

1757

16390

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.2

14.3

149

708

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

14.3

224

1253

TAB00

NOMESCO Finland

Lumbar puncture

2.7

14.2

100

388

M01AE52

ATC

naproxen and esomeprazole; oral

3.0

14.2

281

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.1

14.1

248

R4110

SPAT

3.7

14.1

173

F61.0

ICD-10 Finland

Mixed personality disorders

4.0

14.1

143

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

14.1

299

1847

R5110

SPAT

4.9

14.0

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.3

14.0

120

M02AA10

ATC

ketoprofen; topical

1.8

14.0

243

1407

R06AX13

ATC

loratadine; oral

1.7

14.0

351

2275

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.3

13.9

N03AF01

ATC

carbamazepine; oral, rectal

2.8

13.9

338

NF1AA

NOMESCO Finland

Hip X-ray examination

2.6

13.9

103

412

J01MA12

ATC

levofloxacin; systemic

1.8

13.9

249

1459

F48.0

ICD-10 Finland

Neurasthenia

17.7

13.8

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.6

13.8

104

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

13.7

778

6102

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

7.0

13.6

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

13.6

1133

9585

S43.0

ICD-10 Finland

Dislocation of shoulder joint

3.2

13.5

218

J35.0

ICD-10 Finland

Chronic tonsillitis

2.0

13.4

171

882

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

13.4

173

897

SBB10

NOMESCO Finland

Teeth copy

2.0

13.4

171

883

D06

ICPC

Abdominal pain localized other

2.0

13.4

183

971

R25.2

ICD-10 Finland

Cramp and spasm

3.8

13.3

146

G50.0

ICD-10 Finland

Trigeminal neuralgia

4.4

13.3

108

R60.0

ICD-10 Finland

Localized oedema

2.1

13.3

149

731

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.6

13.3

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

13.3

441

3070

H57.1

ICD-10 Finland

Ocular pain

2.9

13.3

294

N03AG01

ATC

valproic acid; systemic, rectal

2.3

13.2

129

592

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.9

13.2

137

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.6

13.2

367

S06.0

ICD-10 Finland

Concussion

1.9

13.2

195

1065

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.0

13.2

260

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

13.2

104

430

SPAT1310

SPAT

Counselling related to known health issue

1.5

13.2

574

4252

N81.6

ICD-10 Finland

Rectocele

2.3

13.2

124

562

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandipular joint with high intensity magnet

40.4

13.2

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.9

13.1

138

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

4.2

13.1

119

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

13.1

471

3340

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.8

13.1

314

R06.4

ICD-10 Finland

Hyperventilation

3.7

12.9

150

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.4

12.9

107

SPAT1284

SPAT

Extensive health certificate

2.9

12.8

282

S83.0

ICD-10 Finland

Dislocation of patella

3.2

12.8

215

M77.4

ICD-10 Finland

Metatarsalgia

2.3

12.8

121

548

SPAT1301

SPAT

No procedures

1.5

12.8

526

3843

K59.0

ICD-10 Finland

Constipation

2.7

12.8

330

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.6

12.8

372

N02CC06

ATC

eletriptan; oral

2.3

12.7

116

518

Z08

ICPC

Social welfare problem

5.4

12.7

N02CD01

ATC

erenumab; parenteral

4.6

12.7

XCK00

NOMESCO Finland

Perimetry

2.5

12.7

402

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

12.6

167

877

OAB44

SPAT

2.3

12.5

112

495

S29

ICPC

Skin symptom/complaint other

1.7

12.5

267

1647

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

12.5

609

4610

F32

ICD-10 Finland

Depressive episode

2.1

12.4

140

686

E66.8

ICD-10 Finland

Other obesity

2.2

12.4

134

647

N05CF02

ATC

zolpidem; oral

1.6

12.4

333

2192

M25.9

ICD-10 Finland

Joint disorder, unspecified

5.8

12.4

P29

ICPC

Psychological sympt/compl other

2.0

12.4

161

838

P76

ICPC

Depressive disorder

2.0

12.4

167

882

R74

ICPC

Upper respiratory infection acute

1.4

12.3

706

5516

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

12.3

286

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.9

12.3

132

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

12.2

120

554

N06BA04

ATC

methylphenidate; oral

2.7

12.2

304

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.5

12.2

372

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.2

12.2

123

576

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

6.8

12.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

12.2

194

1088

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.1

12.1

132

640

XF402

NOMESCO Finland

ECG with work load test

2.2

12.1

127

605

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

5.5

12.1

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

12.1

190

1062

M13.0

ICD-10 Finland

Polyarthritis, unspecified

5.7

12.1

SPAT1058

SPAT

PEF monitoring instruction

2.1

12.1

144

724

R06AE09

ATC

levocetirizine; oral

1.6

12.1

322

2117

K08.80

ICD-10 Finland

Toothache NOS

1.9

12.0

188

1049

A03FA02

ATC

cisapride; oral, rectal

2.3

12.0

114

519

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.1

12.0

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

12.0

111

500

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

12.0

671

5212

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

11.9

338

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.9

11.9

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

11.9

269

1687

R07.0

ICD-10 Finland

Pain in throat

2.0

11.9

147

750

RF210

NOMESCO Finland

3.1

11.8

217

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

11.8

188

1056

WX290

NOMESCO Finland

Other blockade of nerve

1.4

11.8

959

7974

RF120

NOMESCO Finland

5.5

11.8

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.8

11.8

269

N01

ICPC

Headache

1.7

11.8

283

1805

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.0

11.7

156

822

N06AA12

ATC

doxepin; systemic

2.7

11.6

296

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

4.6

11.6

SPAT1202

SPAT

Intra-articular injection

3.7

11.6

134

WX722

NOMESCO Finland

PEEP

3.1

11.6

198

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

11.5

151

789

A92

ICPC

Allergy/allergic reaction NOS

2.7

11.5

309

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

11.5

565

4268

N05CD07

ATC

temazepam; oral

2.1

11.5

131

645

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.8

11.5

130

D07AC01

ATC

betamethasone; topical

1.5

11.5

551

4142

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

11.5

144

740

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

11.4

131

648

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.2

11.4

101

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

120.7

11.4

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.7

11.4

287

SPAT1059

SPAT

Spirometry at the office

2.6

11.4

337

L04AB06

ATC

golimumab; parenteral

5.2

11.4

M15

ICD-10 Finland

Polyarthrosis

3.0

11.4

212

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

11.3

387

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.3

11.3

109

500

ZXH06

SPAT

3.2

11.3

185

N06AX26

ATC

vortioxetine; oral

2.1

11.2

136

688

L50.9

ICD-10 Finland

Urticaria, unspecified

2.4

11.2

409

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.1

11.2

103

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

11.2

382

R13

ICD-10 Finland

Dysphagia

2.5

11.2

346

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

11.2

108

497

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

11.1

298

1957

L18

ICPC

Muscle pain

2.6

11.1

321

M01AB01

ATC

indometacin; systemic, rectal

2.8

11.0

257

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

11.0

323

2172

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

11.0

102

460

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

9.3

11.0

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

11.0

263

1676

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.5

10.9

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

10.9

208

1242

R03AK08

ATC

formoterol and beclometasone; inhalant

2.7

10.9

284

S33.6

ICD-10 Finland

Sprain and strain of sacroiliac joint

15.6

10.8

G44.8

ICD-10 Finland

Other specified headache syndromes

4.1

10.8

102

K80

ICPC

Cardiac arrhythmia NOS

2.2

10.8

105

484

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

10.8

155

841

M22.1

ICD-10 Finland

Recurrent subluxation of patella

6.2

10.7

SPAT1263

SPAT

Sampling

1.4

10.7

773

6252

R39.1

ICD-10 Finland

Other difficulties with micturition

4.1

10.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.9

10.7

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

28.2

10.7

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.6

10.7

133

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

10.7

271

1752

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.9

10.7

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

10.7

424

3055

J01FA15

ATC

telithromycin; oral

1.8

10.7

191

1117

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.9

10.7

215

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

10.7

116

560

R03BB04

ATC

tiotropium bromide; inhalant

2.2

10.7

105

488

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

10.7

293

1936

ZXA10

NOMESCO Finland

Bilateral

1.6

10.6

263

1689

C08CA05

ATC

nifedipine; systemic

2.5

10.6

337

N02CD03

ATC

fremanezumab; systemic

5.1

10.6

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

5.8

10.6

J01FA01

ATC

erythromycin; systemic

1.6

10.6

328

2234

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

2.7

10.5

263

R03AC13

ATC

formoterol; inhalant

2.5

10.5

351

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

10.5

235

1469

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

7.4

10.5

A29

ICPC

General symptom/complaint other

1.9

10.5

169

952

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

10.4

108

513

M15.8

ICD-10 Finland

Other polyarthrosis

4.8

10.4

N02CC04

ATC

rizatriptan; oral

1.9

10.4

163

911

R35

ICD-10 Finland

Polyuria

2.6

10.4

292

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

16.1

10.3

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.0

10.3

102

M43.0

ICD-10 Finland

Spondylolysis

3.7

10.3

117

C10AC01

ATC

colestyramine; oral

3.2

10.3

170

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.8

10.3

112

K07.61

ICD-10 Finland

Cracking jaw joint

2.8

10.3

231

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

6.1

10.3

G81.9

ICD-10 Finland

Hemiplegia, unspecified

6.1

10.3

L84

ICPC

Back syndrome without radiat pain

2.4

10.3

360

J01DA06

ATC

[U] cefuroxime; systemic

1.6

10.3

261

1689

JAH01

NOMESCO Finland

Laparoscopy

2.1

10.3

112

545

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

7.1

10.3

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

3.2

10.2

160

R29

ICPC

Respiratory symptom/complaint other

2.0

10.2

122

616

J46

ICD-10 Finland

Status asthmaticus

2.9

10.2

211

W0A10

NOMESCO Finland

Mapping of psychosocial situation

13.2

10.2

ZYC01

SPAT

1.9

10.1

144

777

N06AX17

ATC

milnacipran; oral

4.7

10.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

10.1

451

M01CB03

ATC

auranofin; oral

7.9

10.1

S21

ICPC

Skin texture symptom/complaint

1.8

10.1

194

1158

B02AA02

ATC

tranexamic acid; systemic

1.5

10.1

338

2345

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.0

10.0

131

682

H02AB09

ATC

hydrocortisone; systemic

3.1

10.0

179

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

10.0

421

P06

ICPC

Sleep disturbance

1.8

10.0

190

1130

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.9

10.0

156

868

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.0

10.0

194

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.9

10.0

214

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.2

9.9

158

N30.0

ICD-10 Finland

Acute cystitis

1.6

9.9

268

1763

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

9.9

184

1086

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.8

9.9

106

SPAT1211

SPAT

Application of soft bandage

1.9

9.9

150

829

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

9.8

331

A02BA04

ATC

nizatidine; systemic

2.2

9.8

101

480

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.3

9.8

144

SPAT1283

SPAT

Restricted health certificate

1.4

9.7

506

3842

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.6

9.7

270

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.6

9.7

270

WW200

SPAT

1.7

9.7

204

1251

R12

ICD-10 Finland

Heartburn

2.0

9.7

127

665

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.2

9.7

161

M25.4

ICD-10 Finland

Effusion of joint

4.6

9.7

K07.68

ICD-10 Finland

Other disorders of the jaw joint

5.1

9.7

R21

ICPC

Throat symptom/complaint

1.4

9.7

499

3779

R09

ICPC

Sinus symptom/complaint

1.7

9.6

185

1104

L19

ICPC

Muscle symptom/complaint NOS

3.0

9.6

179

K58

ICD-10 Finland

Irritable bowel syndrome

2.8

9.6

218

W19

ICD-10 Finland

Unspecified fall

1.9

9.6

132

705

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

9.6

153

862

1220

FHL

Arthroscopy

2.7

9.5

250

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

9.5

209

S22.3

ICD-10 Finland

Fracture of rib

2.4

9.5

351

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.7

9.5

243

H02AA02

ATC

fludrocortisone; oral

9.1

9.5

SPAT1312

SPAT

General health counselling

1.4

9.5

610

4809

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.4

9.5

131

R06AX26

ATC

fexofenadine; oral

1.9

9.4

148

827

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.1

9.4

108

537

EBA00

NOMESCO Finland

Extraction of tooth

1.4

9.4

568

4429

K11.7

ICD-10 Finland

Disturbances of salivary secretion

100.5

9.4

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

9.4

112

565

R03BB01

ATC

ipratropium bromide; inhalant

3.2

9.4

154

H93.1

ICD-10 Finland

Tinnitus

2.2

9.4

434

SBA10

NOMESCO Finland

Measurement of excretion of saliva

5.9

9.4

SPAT1106

SPAT

Acupuncture

5.6

9.4

Z00.8

ICD-10 Finland

Other general examinations

1.9

9.4

136

741

E87.6

ICD-10 Finland

Hypokalaemia

3.2

9.3

149

H01

ICPC

Ear pain/earache

1.6

9.3

224

1425

EMB10

NOMESCO Finland

Tonsillectomy

1.8

9.3

167

976

RF220

NOMESCO Finland

4.4

9.3

SPAT1254

SPAT

Administration of medicine

1.6

9.3

224

1426

M23.8

ICD-10 Finland

Other internal derangements of knee

2.3

9.3

360

R01AD11

ATC

triamcinolone; nasal

1.8

9.3

167

977

S80.0

ICD-10 Finland

Contusion of knee

1.9

9.3

130

698

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.7

9.3

224

D07AC13

ATC

mometasone; topical

1.4

9.3

478

3617

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

9.3

242

1576

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.5

9.3

274

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.5

9.3

118

N02CC05

ATC

almotriptan; oral

2.0

9.3

125

661

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

9.2

109

549

RS222

NOMESCO Finland

4.7

9.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

9.2

194

1189

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.2

9.2

432

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

9.2

260

1730

M01CB01

ATC

sodium aurothiomalate; parenteral

4.5

9.2

A03

ICPC

Fever

1.5

9.1

357

2554

F60.5

ICD-10 Finland

Anankastic personality disorder

3.7

9.1

104

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

9.1

289

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

9.1

256

N05AA02

ATC

levomepromazine; systemic

2.7

9.1

231

RF421

NOMESCO Finland

8.3

9.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

9.1

9.0

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

9.1

9.0

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

9.0

294

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

9.0

216

1373

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.5

9.0

285

F93.89

ICD-10 Finland

Other childhood emotional disorders

4.0

8.9

M05BA07

ATC

risedronic acid; oral

3.7

8.9

101

M23.5

ICD-10 Finland

Chronic instability of knee

5.3

8.9

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

4.7

8.9

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

8.9

378

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

8.9

391

R4190

NOMESCO Finland

Nutritional therapy

2.5

8.9

280

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.4

8.9

299

K11.2

ICD-10 Finland

Sialoadenitis

2.7

8.9

219

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

8.9

262

E000006

ATC

1.9

8.9

124

666

KMAK

NOMESCO Finland

1.3

8.8

1034

8950

J20

ICD-10 Finland

Acute bronchitis

1.8

8.8

164

972

N06AG02

ATC

moclobemide; oral

2.5

8.8

283

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

8.7

107

547

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

4.4

8.7

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.4

8.7

L04

ICPC

Chest symptom/complaint

2.1

8.7

471

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.1

8.7

471

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.8

8.7

192

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

8.7

100

498

C05AA08

ATC

fluocortolone; rectal, topical

1.6

8.7

208

1324

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

8.6

108

555

SPAT1235

SPAT

Mental health, emotional support

5.1

8.6

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.1

8.6

153

G04CA02

ATC

tamsulosin; oral

2.5

8.6

272

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

5.5

8.6

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.4

8.6

115

XQ802

NOMESCO Finland

Epicutan test

2.1

8.6

494

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.4

8.5

303

XG405

NOMESCO Finland

Education on PEF monitoring

3.7

8.5

NG1DA

NOMESCO Finland

X-ray of knees

3.8

8.5

M25.3

ICD-10 Finland

Other instability of joint

10.1

8.5

N04BC09

ATC

rotigotine; transdermal

10.1

8.5

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

8.5

345

I73.0

ICD-10 Finland

Raynaud syndrome

3.4

8.5

116

R55

ICD-10 Finland

Syncope and collapse

1.9

8.5

127

698

SPAT1153

SPAT

Removal of sutures

1.4

8.5

421

3156

N06AA06

ATC

trimipramine; systemic

3.2

8.5

138

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

20.1

8.5

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

8.4

159

945

F32.8

ICD-10 Finland

Other depressive episodes

3.2

8.4

133

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.0

8.4

100

503

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

8.4

364

2656

R52.0

ICD-10 Finland

Acute pain

2.4

8.4

288

R03AC12

ATC

salmeterol; inhalant

2.5

8.4

261

D19

ICPC

Teeth/gum symptom/complaint

1.4

8.4

507

3940

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.2

8.4

407

OAB47

SPAT

2.4

8.4

300

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

8.4

362

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

8.4

170

1034

B01AA03

ATC

warfarin; systemic

1.9

8.3

120

651

R06.2

ICD-10 Finland

Wheezing

2.3

8.3

342

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.4

8.3

302

E000001

ATC

1.4

8.3

377

2778

9245

FHL

Reconstruction or plastic surgery of ankle ligaments

6.2

8.3

IHZ04

SPAT

6.2

8.3

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

8.3

335

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.2

8.3

402

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

8.2

369

N07CA01

ATC

betahistine; oral

2.2

8.2

392

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.5

8.2

248

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

8.2

267

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

8.2

267

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

8.2

441

3355

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.9

8.2

162

ZX100

NOMESCO Finland

Oral

4.3

8.2

XQ820

NOMESCO Finland

Exposure to medicinal substance

6.5

8.2

A07EC02

ATC

mesalazine; oral, rectal

2.0

8.2

482

J01

ICD-10 Finland

Acute sinusitis

1.9

8.2

119

651

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.1

8.2

433

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.4

8.1

SPAT1260

SPAT

Consultation of another employee

1.5

8.1

284

1980

SXC05

NOMESCO Finland

Other oral or dental procedure

1.9

8.1

122

673

WZC00

SPAT

2.0

8.1

100

514

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.3

8.1

121

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

8.1

263

J01DC02

ATC

cefuroxime; systemic

1.9

8.1

116

630

N89

ICPC

Migraine

2.0

8.1

106

558

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.1

8.1

138

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

8.0

245

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

8.0

620

5012

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.8

8.0

188

J01MA14

ATC

moxifloxacin; systemic

1.9

8.0

123

682

TEG00

NOMESCO Finland

Punction of mandibular joint

10.1

8.0

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.2

8.0

369

F84.5

ICD-10 Finland

Asperger syndrome

5.0

8.0

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.6

8.0

227

M25.0

ICD-10 Finland

Haemarthrosis

6.3

8.0

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.2

8.0

122

N81.1

ICD-10 Finland

Cystocele

2.0

8.0

467

IGY02

SPAT

5.3

8.0

M07.3

ICD-10 Finland

Other psoriatic arthropathies

4.6

8.0

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

5.6

8.0

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

8.0

115

626

N05BA12

ATC

alprazolam; oral

1.7

8.0

173

1074

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

7.9

483

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.6

7.9

222

J01CA08

ATC

pivmecillinam; oral

1.3

7.9

882

7528

LCA16

NOMESCO Finland

Destruction of endometrium

2.9

7.9

161

OAB42

SPAT

1.9

7.9

109

583

TAC99

NOMESCO Finland

Other blockade for chronic pain

6.6

7.9

SPAT1255

SPAT

Intravenous administration of medicine

2.1

7.9

413

SPAT1395

SPAT

Health check-up of persons outside student and working life

2.8

7.9

175

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.3

7.9

312

TAB20

NOMESCO Finland

Epidural puncture

5.2

7.9

R05FB02

ATC

cough suppressants and expectorants

1.4

7.8

544

4317

M01AC01

ATC

piroxicam; systemic, rectal

1.7

7.8

160

973

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

7.8

281

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.1

7.8

441

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.7

7.8

L04AA17

ATC

[U] adalimumab; parenteral

8.5

7.8

ACC51

NOMESCO Finland

Release of median nerve

1.8

7.8

123

689

A04AA01

ATC

ondansetron; systemic, rectal

1.9

7.8

108

580

N06AX05

ATC

trazodone; oral

2.5

7.8

237

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.0

7.8

484

B81

ICPC

Anaemia vit B12/folate deficiency

3.0

7.8

142

L50.8

ICD-10 Finland

Other urticaria

2.9

7.7

158

N02AC04

ATC

dextropropoxyphene; oral

3.3

7.7

109

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.8

7.7

171

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

7.7

213

NHF25

NOMESCO Finland

Operation for debridement of ankle joint, arthroscopic

4.3

7.7

K08.3

ICD-10 Finland

Retained dental root

2.1

7.7

411

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

7.7

314

2261

N76.0

ICD-10 Finland

Acute vaginitis

1.6

7.7

178

1123

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.3

7.7

321

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.3

7.7

110

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

7.7

216

1435

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

7.6

404

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.4

7.6

282

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

7.6

134

778

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

7.6

148

889

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

6.7

7.6

M03AX01

ATC

botulinum toxin; parenteral

3.0

7.6

133

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

7.6

273

G04BD12

ATC

mirabegron; oral

1.9

7.6

102

542

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

7.6

127

730

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

3.7

7.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

7.6

514

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

7.6

186

1192

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

7.5

132

768

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.4

7.5

266

XG410

NOMESCO Finland

Flow-volume spirometry

2.4

7.5

248

M05BX04

ATC

denosumab; parenteral

2.6

7.5

193

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

7.5

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

3.9

7.5

RF420

NOMESCO Finland

3.7

7.5

R03BC03

ATC

nedocromil; inhalant

1.9

7.5

111

612

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

7.4

188

1212

S03.0

ICD-10 Finland

Dislocation of jaw

4.4

7.4

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

7.4

161

995

F01

ICPC

Eye pain

2.5

7.4

241

Q76.9

ICD-10 Finland

Congenital malformation of bony thorax, unspecified

80.4

7.4

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

80.4

7.4

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

798

2695

4.07

203.90

1.6

1.3

titre

397.9

390.9

0.05

156

473

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

913

3460

3.79

195.81

1.5

1.3

u/ml

15.7

9.4

0.79

440

1487

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

909

3623

3.56

177.18

1.5

1.3

iu/ml

29.1

24.2

0.42

264

1090

(3015171) Extractable nuclear Ab [Units/volume] in Serum

357

739

5.57

167.17

1.3

1.2

u/ml

0.3

0.4

0.64

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

867

3880

3.03

131.58

2.1

1.9

u/l

102.9

155.6

2.31

829

3682

(3013707) Erythrocyte sedimentation rate by Westergren method

1897

13311

3.99

123.18

6.4

3.4

mm/h

9.1

9.7

2.25

1833

12466

(3006315) Basophils [#/volume] in Blood

1470

8984

2.90

120.23

7.4

5.4

e9/l

0.0

0.44

1346

7881

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1839

12731

3.64

120.20

8.2

6.3

u/l

71.1

73.2

2.23

1783

12001

(3019198) Lymphocytes [#/volume] in Blood

1500

9317

2.89

117.96

7.4

5.4

e9/l

2.1

2.0

2.57

1396

8406

(3001604) Monocytes [#/volume] in Blood

1456

8956

2.83

115.72

7.3

5.4

e9/l

0.5

1.02

1341

7879

(3013650) Neutrophils [#/volume] in Blood by Automated count

1595

10303

2.96

115.13

9.5

8.1

e9/l

4.0

3.9

0.51

1469

9090

(3013115) Eosinophils [#/volume] in Blood

1492

9323

2.84

114.46

7.6

5.6

e9/l

0.2

0.13

1394

8349

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1201

7019

2.56

100.59

4.9

5.5

mmol/l

1.2

1.32

1065

5921

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1247

7522

2.51

95.99

2.9

2.2

nmol/l

74.8

74.3

0.29

1188

7028

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1073

6244

2.40

86.59

4.6

4.8

mmol/l

1.2

0.39

996

5687

(3022096) Basophils/100 leukocytes in Blood

1278

8085

2.38

84.29

7.6

5.4

0.7

0.35

1221

7538

(3019069) Monocytes/100 leukocytes in Blood

1312

8462

2.35

81.76

7.7

5.6

8.0

7.9

0.87

1261

7959

(3006504) Eosinophils/100 leukocytes in Blood

1305

8404

2.35

81.52

7.5

5.4

2.6

2.8

1.78

1251

7817

(3018010) Neutrophils/100 leukocytes in Blood

1336

8724

2.34

80.28

7.2

5.2

55.4

56.1

1.78

1280

8200

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

219

547

4.33

79.86

1.9

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

1347

8839

2.34

79.83

7.5

5.3

30.8

30.0

2.40

1292

8291

(42870588) Differential panel, method unspecified - Blood

953

5556

2.26

73.09

7.1

5.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

341

1213

3.14

73.05

12.8

12.1

inr

1.2

1.1

0.80

206

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

196

484

4.35

72.39

1.8

1.2

g/l

0.2

1.62

183

449

(3008898) HLA-B27 [Presence]

301

999

3.33

72.33

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

199

504

4.24

71.07

1.7

1.2

g/l

1.2

0.26

187

468

(3036481) Cortisol [Moles/volume] in Serum or Plasma

426

1742

2.79

70.76

2.3

2.0

nmol/l

357.3

383.6

1.88

401

1603

(3005719) IgG [Mass/volume] in Serum or Plasma

335

1202

3.11

70.58

3.3

2.4

g/l

9.7

10.3

2.58

313

1106

(3002582) Erythrocytes [#/volume] in Urine

815

4516

2.27

70.02

3.6

2.7

e6/l

50.0

57.2

0.09

697

3351

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1231

8086

2.18

68.56

5.2

umol/l

8.8

9.6

3.63

1169

7583

(3018095) Leukocytes [#/volume] in Urine

961

5745

2.19

67.93

4.5

3.1

e6/l

53.8

76.5

0.76

756

3709

(40758558) Short blood count panel - Blood

798

4452

2.24

66.78

6.1

6.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

867

5008

2.20

66.49

2.9

2.4

u/l

52.4

55.2

1.07

822

4634

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

190

490

4.15

66.14

1.3

1.1

u/ml

7.4

9.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

954

5757

2.16

65.09

2.0

1.7

pmol/l

100.9

98.5

0.93

534

3050

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

174

425

4.36

65.07

1.3

1.1

u/ml

11.4

2.8

0.72

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

172

417

4.39

64.94

1.3

1.1

u/ml

2.1

1.9

0.12

(3048689) Calprotectin [Mass/mass] in Stool

580

2871

2.38

64.00

2.7

2.4

ug/g

113.0

95.8

0.61

471

2254

(3024561) Albumin [Mass/volume] in Serum or Plasma

992

6135

2.12

62.88

4.3

4.2

g/l

37.1

36.9

0.61

935

5720

(3013826) Glucose [Moles/volume] in Serum or Plasma

1326

9171

2.11

61.99

4.1

3.9

mmol/l

6.0

6.3

11.92

1262

8271

(3018418) pH of Serum or Plasma

741

4144

2.19

60.44

3.3

7.4

0.50

114

809

(3035350) Ketones [Presence] in Urine by Test strip

1314

9107

2.09

60.44

4.5

3.1

estimate

0.0

0.50

245

1787

(3021601) Nitrite [Presence] in Urine by Test strip

1312

9136

2.07

58.96

5.9

4.2

estimate

0.0

0.50

272

1826

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

159

395

4.26

58.06

1.2

1.1

u/ml

11.3

18.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

797

4651

2.12

57.69

5.3

3.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1655

12646

2.23

57.28

5.3

3.7

—

(3026782) Osmolality of Urine

564

2876

2.29

57.25

3.4

2.4

mosm/kgh2o

511.7

533.6

1.46

515

2447

(3009261) Glucose [Presence] in Urine by Test strip

1314

9217

2.05

57.10

4.6

3.1

estimate

0.0

1.32

273

1796

(3021589) Normoblasts [#/volume] in Blood

1200

8168

2.03

56.49

9.6

7.6

e9/l

0.0

0.69

1025

6682

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

136

309

4.62

55.63

1.2

1.1

u/ml

1.3

5.7

0.47

(3030467) Casts [#/volume] in Urine by Automated count

723

4112

2.13

55.60

3.4

2.6

e6/l

0.2

0.3

4.20

595

3016

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

338

1378

2.71

55.57

2.3

au/ml

16.4

23.7

0.78

114

(4034850)

191

570

3.57

53.75

9.5

7.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

749

4379

2.07

53.03

1.7

1.4

g/l

1.9

2.1

4.04

507

2762

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

814

4908

2.04

52.94

3.1

2.5

ng/l

14.6

44.7

1.79

371

2175

(3019550) Sodium [Moles/volume] in Serum or Plasma

2093

18057

3.96

52.84

14.0

9.7

mmol/l

139.7

139.6

0.67

2070

17539

(3026493) Urate [Moles/volume] in Serum or Plasma

672

3778

2.12

52.78

2.2

2.1

umol/l

2507.3

3199.0

0.24

606

3360

(3023103) Potassium [Moles/volume] in Serum or Plasma

2094

18121

3.92

51.54

14.1

9.7

mmol/l

3.9

1.74

2068

17547

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

712

4166

2.05

49.68

2.5

2.1

mg/l

2.7

0.11

638

3586

(3000850) Epithelial cells [#/volume] in Urine

577

3130

2.14

49.24

2.8

2.3

e6/l

7.0

9.1

2.04

513

2739

(3015377) Calcium [Moles/volume] in Serum or Plasma

827

5138

1.97

48.41

2.8

3.1

mmol/l

2.3

2.4

1.82

758

4660

(3017181) Myelocytes/100 leukocytes in Blood

316

1337

2.59

47.82

4.8

4.1

0.5

0.9

1.90

309

(3021440) Promyelocytes/100 leukocytes in Blood

306

1277

2.62

47.62

4.8

4.2

0.0

0.1

2.14

282

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

448

2223

2.27

47.56

3.1

2.3

e6/l

5.5

4.7

0.41

307

1091

(3028026) IgM [Mass/volume] in Serum or Plasma

248

932

2.87

47.28

2.1

1.8

g/l

1.3

1.4

0.68

232

866

(3025159) Blasts/100 leukocytes in Blood

296

1221

2.64

47.14

4.9

4.2

0.0

0.7

0.82

234

(3019150) Specific gravity of Urine by Refractometry

667

3905

2.01

45.79

4.6

3.3

kg/l

1.0

0.87

571

(3030981) Hyaline casts [#/volume] in Urine by Automated count

195

652

3.18

45.63

2.8

2.5

e6/l

0.2

0.45

188

619

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

475

2460

2.19

45.16

2.3

2.6

ng/l

552.9

629.8

0.18

391

1977

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

300

1275

2.57

44.84

1.3

au/ml

17.1

33.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1988

16998

2.67

44.32

13.1

8.4

ml/min/173m2

93.6

92.2

2.81

1787

13783

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1893

15845

2.35

44.09

5.2

4.2

pmol/l

14.4

14.3

0.73

1813

14842

(3021960) Folate [Moles/volume] in Serum or Plasma

552

3054

2.08

44.05

1.5

1.4

nmol/l

20.5

21.2

0.60

510

2715

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2121

18839

4.06

43.07

17.2

9.8

mg/l

15.4

18.8

7.31

1811

14367

(3028192) IgG subclass 2 [Mass/volume] in Serum

165

5.38

42.80

1.6

1.4

g/l

2.8

2.9

0.19

115

(3024139) IgG subclass 3 [Mass/volume] in Serum

165

5.38

42.80

1.6

1.4

g/l

0.3

0.4

1.52

116

(3027135) IgG subclass 1 [Mass/volume] in Serum

166

5.35

42.51

1.6

1.4

g/l

6.4

6.3

0.08

117

(4062490)

168

5.29

41.95

1.8

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

327

1502

2.38

41.11

1.5

1.3

u/ml

139.4

178.3

0.71

306

1403

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1033

7174

1.83

40.86

4.7

3.1

—

(36304419) Bacteria [Presence] in Urine

682

4158

1.93

40.75

3.4

2.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

413

2109

2.18

40.25

3.0

3.3

mmol/l

0.8

0.11

384

1980

(40768797) Stomach Pathology biopsy report

431

2250

2.14

39.65

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

906

6100

1.82

39.22

3.2

2.9

u/l

25.7

29.5

3.81

881

5828

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

233

943

2.64

38.25

1.7

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2149

19452

4.68

38.22

16.8

10.4

umol/l

66.4

67.0

0.81

2149

19443

(3024980) IgG subclass 4 [Mass/volume] in Serum

105

263

4.14

37.81

1.6

1.5

g/l

0.4

0.6

1.21

201

(3023368) Bacteria identified in Blood by Culture

543

3135

1.97

37.67

3.9

3.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

279

1240

2.43

37.58

3.9

0.4

0.7

0.77

227

(3029937) Albumin [Presence] in Urine by Test strip

751

4828

1.84

37.39

5.2

3.3

estimate

0.0

1.34

272

1809

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2034

17892

2.70

37.11

6.2

4.9

mu/l

1.6

2.0

2.02

1981

16977

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

805

5303

1.81

36.88

1.4

1.3

u/ml

0.9

1.4

0.76

261

1487

(3011397) Hemoglobin [Presence] in Urine by Test strip

657

4070

1.87

36.68

4.3

3.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

197

4.61

36.59

1.2

1.1

u/ml

24.4

55.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

438

2385

2.04

35.64

2.8

2.2

e6/l

1.2

1.3

0.31

291

1250

(3004616) Nuclear Ab [Presence] in Serum

177

4.77

35.64

1.4

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1325

10160

1.76

35.27

3.6

2.8

ug/l

67.6

0.00

1278

9616

(3013512) EKG study

608

3727

1.87

34.78

3.2

2.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

441

2437

2.01

34.32

2.4

2.5

mmol/l

2.4

0.22

390

2124

(3031040) Bacteria [#/volume] in Urine by Automated count

1513

12127

1.78

33.74

5.4

3.8

e6/l

306.3

886.0

1.00

119

(3019309) Folate [Moles/volume] in Red Blood Cells

403

2169

2.05

33.69

1.9

1.6

nmol/l

1063.7

1189.4

2.25

334

1680

(3045414) Leukocytes [Presence] in Urine

200

798

2.66

33.67

1.9

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

522

3085

1.91

33.24

1.7

1.6

pmol/l

106637595.7

39635704.3

0.65

452

2687

(3000330) Specific gravity of Urine by Test strip

183

706

2.74

32.90

3.4

2.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

180

695

2.73

32.30

2.1

u/l

39.5

39.7

0.06

168

647

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

126

404

3.25

31.47

1.6

1.5

titre

360.0

320.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2146

19700

3.99

31.12

12.9

8.2

u/l

25.0

24.2

1.34

2121

19129

(3004789) Transferrin [Mass/volume] in Serum or Plasma

375

2031

2.02

30.57

2.3

2.2

g/l

2.5

0.65

357

1877

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1946

17127

2.13

29.70

4.0

3.5

mmol/l

5.6

1.74

1859

16074

(3022948) Iron [Moles/volume] in Serum or Plasma

400

2270

1.93

28.32

2.4

2.2

umol/l

15.1

14.4

1.04

381

2095

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

646

4249

1.74

28.16

1.9

1.7

mg/l

0.7

0.8

1.87

487

3110

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

340

1830

2.01

28.04

2.4

2.3

23.7

0.00

306

1579

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

130

4.88

27.91

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

130

4.88

27.91

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

130

4.88

27.91

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

130

4.88

27.91

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

130

4.88

27.91

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

131

4.84

27.66

1.2

1.1

—

(3022145) Colonoscopy Study observation

334

1800

2.01

27.41

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

339

1837

2.00

27.39

2.5

umol/l

5.7

5.6

0.05

281

1538

(3014051) Protein [Presence] in Urine by Test strip

120

406

3.07

27.38

2.0

1.9

—

(3026008) Bacteria identified in Urine by Culture

733

5028

1.68

27.19

3.2

2.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

129

4.83

27.19

1.4

1.5

ug/l

5.2

7.1

0.93

110

(3000570) Elastase.pancreatic [Mass/mass] in Stool

121

416

3.02

26.85

1.3

ug/g

336.5

320.7

0.30

199

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

190

828

2.42

26.46

1.6

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

276

3.47

26.26

2.1

1.7

e6/l

4634.6

11153.6

1.97

202

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

407

2390

1.86

25.72

2.9

ng/l

153.8

320.0

0.79

176

1291

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

360

2038

1.92

25.46

1.3

1.2

iu/ml

109.5

162.8

1.64

142

804

(3032080) INR in Blood by Coagulation assay

714

4933

1.66

25.40

5.3

inr

1.1

0.55

278

1675

(40761535) Cells panel - Urine sediment

235

1141

2.19

25.35

4.0

3.1

—

(3044640) Blood type and Crossmatch panel - Blood

784

5555

1.64

25.19

2.3

2.0

—

(3044889) 12 lead EKG panel

1375

11151

1.62

25.16

3.2

2.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

7.71

25.09

1.2

1.1

—

(3024263) Appearance of Synovial fluid

7.01

25.05

3.8

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

180

787

2.40

24.86

1.9

2.5

g/l

67.4

0.05

167

736

(3024354) Oxygen [Partial pressure] in Venous blood

189

847

2.35

24.68

3.1

3.5

kpa

4.3

4.8

2.81

182

820

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

5.64

24.47

1.1

1.2

u/l

4.6

5.6

0.72

(3002032) Base excess in Venous blood by calculation

214

1021

2.21

24.08

3.2

4.0

mmol/l

1.9

1.8

0.23

175

821

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

129

491

2.73

23.74

2.7

3.2

0.7

0.45

118

473

(3021447) Carbon dioxide [Partial pressure] in Venous blood

213

1029

2.18

23.22

3.2

4.0

kpa

5.9

5.8

0.13

205

999

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

347

1997

1.87

23.18

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

203

983

2.17

21.97

4.7

6.2

mmol/l

1.2

0.02

193

942

(3003458) Phosphate [Moles/volume] in Serum or Plasma

287

1582

1.94

21.79

4.0

5.4

mmol/l

1.0

1.1

0.26

272

1484

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1753

15363

1.68

21.07

4.9

4.2

mmol/mol

36.7

37.7

7.16

1685

14518

(3018677) aPTT in Platelet poor plasma by Coagulation assay

335

1972

1.82

20.67

2.1

2.2

29.1

29.2

0.18

323

1907

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

274

1517

1.92

20.48

2.8

3.3

pmol/l

4.6

0.03

251

1361

(3038026) Centromere Ab [Units/volume] in Serum

4.77

20.36

1.3

1.1

u/ml

15.6

23.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.61

20.03

1.1

—

(3025941) Bacteria identified in Stool by Culture

233

1234

1.99

19.80

1.3

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

203

3.48

19.79

1.2

1.3

nmol/l

0.5

0.26

197

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

11.15

19.78

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

137

587

2.42

19.76

1.5

1.6

iu/ml

0.0

0.2

0.78

105

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.85

19.44

2.6

2.8

u/ml

393.9

826.9

2.29

(3028707) Methadone [Presence] in Urine by Screen method

141

617

2.37

19.40

2.1

2.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

13.95

19.36

1.7

1.9

mg/l

1.3

0.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

168

797

2.20

19.11

2.0

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

137

597

2.38

19.03

2.1

2.2

—

(3033658) Prothrombin time (PT) actual/Normal

575

3994

1.59

18.99

3.8

3.3

99.1

98.3

0.38

551

3875

(3042936) Bacteria identified in Isolate by Culture

333

2008

1.78

18.85

2.0

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

114

4.28

18.59

1.1

nmol/l

0.1

9.6

0.86

(3041096) Erythrocytes [Presence] in Urine by Automated

726

5339

1.54

18.55

4.0

2.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

221

1176

1.98

18.50

2.2

2.8

1.6

1.8

1.25

200

1056

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

14.27

18.49

1.7

1.9

mg/l

1.1

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

297

2.94

18.37

1.5

2.5

ug/l

126.6

259.8

1.63

269

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

269

1539

1.85

18.08

2.4

2.2

u/l

29.7

36.8

2.07

210

1287

(3017315) Amylase [Enzymatic activity/volume] in Urine

4.72

17.53

1.4

1.2

u/l

208.7

337.9

0.48

(3013139) Helicobacter pylori Ag [Presence] in Stool

235

1300

1.90

17.52

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

317

1924

1.76

17.47

1.9

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

227

1250

1.91

17.15

3.0

2.2

ml/min/173m2

77.1

77.2

0.02

466

(3020891) Body temperature

104

421

2.54

16.95

4.3

4.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

114

487

2.41

16.56

1.2

1.4

mg/l

402.0

461.8

1.03

109

465

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

116

4.03

16.49

2.3

2.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

187

3.33

16.45

1.2

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.67

16.44

1.1

—

(3022621) pH of Urine by Test strip

210

1143

1.93

16.41

2.8

2.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

104

430

2.49

16.22

1.3

1.6

e6/l

1816.0

10006.5

0.46

347

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

104

431

2.48

16.14

1.2

1.4

mmol/l

3.4

3.7

1.86

404

(3023520) Reticulocytes [#/volume] in Blood

160

796

2.09

16.10

1.8

2.7

e9/l

72.0

73.5

0.19

114

570

(3011288) Drugs identified in Urine by Screen method

184

965

1.99

16.02

2.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

309

2.75

15.98

1.3

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

338

2.67

15.96

2.1

1.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

338

2.67

15.96

2.1

1.8

g/l

7.2

7.4

0.43

281

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

338

2.67

15.96

2.1

1.8

g/l

3.6

3.7

0.40

257

(4010399)

198

1069

1.94

15.85

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

220

1232

1.87

15.75

3.3

4.2

u/l

214.7

241.2

2.10

211

1175

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

231

1314

1.85

15.74

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

5.52

15.72

1.8

2.6

e6/l

195.5

169.1

0.26

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

103

431

2.46

15.66

1.3

1.5

e6/l

26.1

19.1

0.17

328

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

2.68

15.56

2.1

1.8

g/l

2.9

3.1

0.84

265

(3011412) CD3 cells [#/volume] in Blood

154

3.50

15.54

1.9

2.9

e9/l

1.6

1.3

0.68

(3044941) Cell count panel - Synovial fluid

199

3.18

15.54

1.9

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

181

958

1.97

15.35

2.9

3.5

ng/l

64.6

73.5

1.37

159

859

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

569

4106

1.52

15.34

2.2

1.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

141

683

2.14

15.21

1.5

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

124

3.77

15.06

2.0

2.5

13.3

12.0

0.38

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1069

8750

1.43

14.88

4.3

3.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

211

3.04

14.71

1.5

1.3

—

37.0

—

(3052851) Hemolysis interference index of Serum or Plasma

419

2.43

14.70

2.7

—

(40761511) CBC panel - Blood by Automated count

2118

20076

2.29

14.44

14.3

9.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

228

1339

1.78

13.96

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

119

562

2.18

13.70

1.3

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

299

2.63

13.70

2.3

2.0

g/l

0.3

0.6

0.60

280

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

118

558

2.18

13.54

1.3

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

195

3.03

13.48

1.3

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

310

2.57

13.25

1.7

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

168

917

1.90

13.00

4.3

7.6

mmol/l

6.0

7.2

2.36

162

891

(42529406) Shigella sp [Presence] in Stool by Culture

118

568

2.14

12.96

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

290

2.61

12.94

4.9

3.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

5.63

12.89

1.8

2.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

304

2.55

12.75

2.2

1.9

g/l

9.9

10.2

0.32

277

(3023410) Appearance of Cerebral spinal fluid

207

2.90

12.73

1.6

1.9

—

(3021788) Differential panel - Synovial fluid

225

2.81

12.59

1.8

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1513

13368

1.42

12.56

3.4

2.8

u/l

38.5

34.5

1.49

1461

12775

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

116

3.58

12.56

1.7

2.9

e6/l

530.8

527.1

0.02

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

385

2657

1.54

12.47

1.7

1.4

1.3

2.50

337

2407

(3000991) Gas panel - Venous blood

166

917

1.88

12.38

5.3

7.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

206

2.86

12.26

1.8

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

423

2.28

12.19

1.2

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

4.07

12.12

3.0

2.9

au/ml

126.8

115.6

—

(3024731) MCV [Entitic volume]

2197

21338

5.37

12.02

23.6

14.8

90.5

90.1

5.97

2188

21132

(3035941) MCH [Entitic mass]

2197

21340

5.35

11.97

23.6

14.8

30.1

30.0

3.50

2188

21132

(3007461) Platelets [#/volume] in Blood

2196

21324

5.12

11.96

23.8

14.9

e9/l

274.4

267.4

6.02

2179

20911

(3026361) Erythrocytes [#/volume] in Blood

2197

21343

5.33

11.90

23.8

14.8

e12/l

4.5

0.11

2178

20901

(3045424) Erythrocytes [Presence] in Urine

273

2.58

11.86

1.6

—

(3010813) Leukocytes [#/volume] in Blood

2197

21346

5.31

11.84

23.8

14.9

e9/l

6.9

6.7

3.33

2176

20894

(44813793)

183

2.94

11.79

1.1

—

(3000494) Fungus identified in Specimen by Culture

293

1925

1.60

11.72

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

173

2.99

11.71

2.3

2.9

1.0

1.5

0.72

136

(3000963) Hemoglobin [Mass/volume] in Blood

2197

21352

5.27

11.70

23.9

14.9

g/l

134.5

133.9

1.86

2191

21141

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

112

3.53

11.70

1.7

3.0

e9/l

0.2

0.25

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

123

627

2.02

11.62

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

407

2.26

11.55

1.3

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

1803

16557

1.48

11.32

18.6

12.0

13.4

0.03

1790

16228

(3009508) Creatinine [Moles/volume] in Urine

549

4150

1.43

11.14

2.6

3.1

mmol/l

7.5

7.7

0.33

478

3623

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

114

576

2.03

11.04

2.9

4.5

mmol/l

24.2

24.1

0.06

523

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

3.43

10.98

2.0

2.9

e6/l

1160.0

797.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

184

1090

1.75

10.91

2.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

143

3.12

10.88

1.0

1.1

u/l

1.1

0.02

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

192

2.80

10.83

1.0

mg/l

201.3

211.3

0.34

167

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

200

2.74

10.60

1.1

mg/l

27.7

33.7

1.19

161

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

106

3.44

10.43

2.2

1.7

49.2

41.8

0.33

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

360

2.27

10.42

1.1

—

(4027681)

163

2.92

10.41

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

354

2.28

10.39

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

197

2.73

10.34

2.2

1.7

mu/l

29.5

45.2

0.92

182

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

343

2.29

10.27

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

263

2.48

10.21

2.3

1.8

g/l

39.9

38.4

1.30

248

(3048929) Epstein Barr virus Ab [Presence] in Serum

154

884

1.80

10.17

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

188

2.75

10.11

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

147

2.96

9.78

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.55

9.78

1.1

1.2

g/l

0.3

1.53

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

135

755

1.84

9.71

2.1

2.0

ug/l

4.5

5.2

0.15

118

680

(1616796) Gas panel - Central venous blood

264

2.43

9.66

2.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

144

823

1.80

9.66

1.6

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

115

612

1.93

9.64

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

721

5818

1.35

9.64

1.9

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

186

1144

1.68

9.63

2.7

3.1

mmol/l

1.2

0.46

156

983

(3029075) Extractable nuclear Ab panel - Serum

4.32

9.59

1.1

—

(3027008) Opiates [Presence] in Urine

216

1386

1.62

9.48

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

261

2.42

9.42

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

261

2.42

9.42

1.3

—

(3028300) Cannabinoids [Presence] in Urine

216

1389

1.62

9.39

2.0

1.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

189

1181

1.66

9.21

1.1

—

131.3

—

(3016879) Cocaine [Presence] in Urine

201

1278

1.63

9.15

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

211

2.55

9.07

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

213

1379

1.60

9.01

2.0

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.68

8.72

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

146

2.84

8.71

1.3

1.2

—

(3009343) pH of Capillary blood

123

692

1.82

8.70

2.7

3.1

7.4

0.35

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

222

2.47

8.66

1.0

1.1

—

(40768443) Skin Pathology biopsy report

118

657

1.84

8.64

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

331

2.18

8.55

1.3

1.2

u/ml

3.3

0.02

105

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

123

698

1.81

8.47

2.7

3.1

kpa

5.1

0.56

116

661

(3027944) Amphetamines [Presence] in Urine

209

1367

1.58

8.47

1.8

1.9

—

(21494755) Public health laboratory ask at order entry panel

188

2848

0.63

8.45

1.2

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.58

8.40

1.4

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

226

2.42

8.34

3.2

3.1

umol/l

30.8

33.0

0.41

203

(3021901) Oxygen saturation in Capillary blood

173

2.63

8.29

2.4

2.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

396

2.06

8.26

1.1

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.36

8.21

1.3

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

176

2.59

8.02

2.9

3.6

mu/l

33.5

30.2

0.16

170

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

288

2042

1.47

8.01

2.3

2.2

u/l

5212.2

6428.9

0.27

815

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

182

2.56

8.01

1.5

1.4

pmol/l

347.6

338.7

0.05

143

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

142

2.78

7.98

1.3

mmol/l

2.3

1.9

0.49

134

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.72

7.90

1.4

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

494

1.92

7.89

2.1

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

466

1.95

7.88

1.3

titre

76.7

89.8

0.33

(3023511) Choriogonadotropin [Units/volume] in Urine

172

1095

1.62

7.80

1.5

1.3

—

(4198724)

122

2.90

7.75

1.9

2.2

—

(40768804) Tissue Pathology biopsy report

908

7757

1.29

7.61

2.1

1.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

169

2.57

7.60

1.3

1.2

u/ml

0.1

0.7

0.81

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

116

671

1.77

7.52

2.7

3.1

mmol/l

1.8

1.4

0.66

492

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

323

2.11

7.45

1.3

u/ml

3.0

4.4

0.57

128

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

3.09

7.44

1.8

2.3

ug/l

22.2

219.7

0.49

(3017143) Hepatitis C virus Ab [Presence] in Serum

390

2963

1.38

7.37

1.6

—

(36660697) Celiac disease serology panel - Serum

261

1845

1.47

7.36

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

180

1178

1.57

7.28

4.9

7.3

kpa

12.7

13.6

1.07

173

1131

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

180

1178

1.57

7.28

4.9

7.3

kpa

5.0

5.1

0.24

175

1129

(3023323) Follitropin [Units/volume] in Serum or Plasma

274

1960

1.45

7.27

1.3

iu/l

24.3

26.2

0.42

239

1671

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

354

2.04

7.23

2.0

2.1

ug/l

0.9

2.1

0.74

328

(3003396) Base excess in Arterial blood by calculation

179

1176

1.57

7.13

4.9

7.4

mmol/l

1.0

0.11

142

892

(3019225) pH of Specimen

197

1325

1.53

7.06

2.8

3.2

—

(3035285) Chloride [Moles/volume] in Venous blood

113

2.86

6.95

2.3

1.9

mmol/l

107.1

106.1

0.79

113

(3041354) Potassium [Moles/volume] in Venous blood

113

2.86

6.95

2.3

1.9

mmol/l

3.9

0.08

113

(3016502) Oxygen saturation in Arterial blood

157

1011

1.60

6.82

5.4

8.0

95.7

96.3

0.60

152

979

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

137

2.65

6.81

2.0

1.7

39.4

54.3

1.03

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

557

1.79

6.77

2.1

1.9

—

(3049717) Cytology report of Urine Cyto stain

257

2.17

6.65

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

104

605

1.75

6.65

1.6

2.1

iu/l

86.7

4.6

0.47

257

(3017732) Neutrophils [#/volume] in Blood

193

1316

1.51

6.50

2.4

2.3

e9/l

4.4

4.1

0.35

161

1126

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

114

685

1.70

6.50

2.4

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

184

1244

1.52

6.45

2.4

2.2

g/l

0.2

0.01

165

1176

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

153

2.51

6.44

1.0

1.1

iu/ml

3.6

9.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.15

6.44

1.1

93.0

99.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.75

6.36

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

576

1.75

6.34

1.5

1.4

u/l

27.2

22.3

0.65

494

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.48

6.29

1.3

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.48

6.29

1.3

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

5.48

6.29

1.3

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.48

6.29

1.3

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

109

2.78

6.22

2.4

1.9

—

(3003181) Sodium [Moles/volume] in Urine

168

2.41

6.21

2.2

1.5

mmol/l

65.1

71.1

0.44

147

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

151

2.48

6.11

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

162

2369

0.66

6.10

1.5

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

144

934

1.58

6.09

1.1

—

0.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

545

4469

1.29

5.99

2.0

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.00

5.96

2.4

3.4

umol/l

153.1

212.0

0.45

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

469

1.80

5.89

1.1

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.96

5.84

1.1

99.4

95.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

376

1.89

5.83

1.1

1.4

u/ml

84.1

107.0

1.33

(3010421) pH of Blood

331

1.93

5.61

2.4

2.8

7.4

0.36

273

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

202

2.20

5.61

1.5

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

594

4968

1.27

5.51

2.2

—

(3002256) Pathology report gross observation

302

2305

1.36

5.48

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

141

2.43

5.46

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

105

648

1.65

5.46

5.3

8.1

mmol/l

24.2

24.4

0.25

603

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

111

695

1.63

5.46

1.9

2.5

ng/l

113.1

97.7

0.11

610

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.80

5.31

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

3.42

5.30

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

198

2707

0.71

5.19

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1398

0.60

5.19

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1885

17990

1.32

5.12

4.2

3.8

mmol/l

2.9

0.51

1802

17026

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1404

0.60

5.10

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1403

0.60

5.09

1.4

—

(3019060) Gas panel - Arterial blood

103

645

1.63

5.08

3.3

6.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1402

0.61

5.07

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

576

1.66

5.05

1.1

u/ml

6.6

5.7

0.14

309

(3030313) Adrenal Ab [Titer] in Serum

4.46

5.03

1.2

1.0

—

(3036489) Thrombin time

108

687

1.60

5.00

1.9

2.3

20.3

21.1

1.47

573

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.65

4.98

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

557

1.66

4.92

2.5

2.7

140.6

162.3

2.65

532

(3010726) Horse dander IgE Ab [Units/volume] in Serum

542

1.67

4.90

1.1

u/ml

1.7

1.9

0.07

128

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

118

2.48

4.88

1.2

titre

250.0

203.8

—

(40767503) Oxygen content in Capillary blood by calculation

242

2.01

4.85

2.5

2.3

17.1

16.8

0.16

116

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

112

1684

0.65

4.83

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

469

1.71

4.79

1.1

u/ml

1.5

4.6

2.37

170

(3021387) Prolactin [Units/volume] in Serum or Plasma

187

1354

1.42

4.67

1.5

1.6

mu/l

288.5

304.8

0.49

173

1204

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

353

1.81

4.66

2.6

3.5

54.4

56.7

0.94

353

(3020682) Albumin/Creatinine [Ratio] in Urine

423

3459

1.28

4.65

3.3

3.9

mg/mmol

5.5

10.0

2.03

253

2191

(3008757) Leukocyte morphology finding [Identifier] in Blood

115

2.45

4.63

1.4

3.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

444

1.71

4.61

1.2

1.3

u/ml

262.9

253.6

0.11

283

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

403

3281

1.28

4.58

2.0

1.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

545

1.64

4.57

1.1

u/ml

0.2

0.9

2.27

233

(3012501) Base excess in Blood by calculation

276

1.91

4.56

2.6

mmol/l

1.7

2.5

2.09

167

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

632

1.59

4.55

1.2

1.1

u/ml

2.7

1.8

0.23

251

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

101

1528

0.64

4.49

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1864

17833

1.29

4.46

3.8

3.5

mmol/l

4.8

0.28

1793

16996

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

192

1409

1.40

4.45

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

449

1.69

4.43

1.5

1.9

—

(3042517) Benzodiazepines panel - Urine

4.02

4.43

2.7

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

325

2585

1.30

4.42

1.9

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

100

2.52

4.38

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

188

1381

1.39

4.33

1.9

1.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

151

2.20

4.31

1.2

1.1

ratio

1.1

1.0

0.70

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

385

1.74

4.29

1.1

u/ml

0.1

0.3

0.93

(3000492) Spirometry study

244

1874

1.34

4.25

1.4

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

190

1404

1.39

4.23

3.0

2.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.64

4.06

1.7

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

155

2.15

4.06

1.6

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.87

4.06

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1853

17762

1.27

4.04

3.7

3.5

mmol/l

1.5

3.07

1777

16875

(3021879) Hepatitis B virus core Ab [Presence] in Serum

246

1909

1.32

4.00

1.5

—

(3012516) Albumin [Mass/volume] in Urine

400

3311

1.25

3.94

2.7

3.2

mg/l

407.8

276.4

0.20

223

2052

(3023430) Cat dander IgE Ab [Units/volume] in Serum

426

1.66

3.93

1.1

u/ml

5.5

4.4

0.16

169

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

131

2.23

3.93

1.4

2.0

33.4

31.8

1.53

131

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.14

3.93

1.1

—

64.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1186

0.63

3.92

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

106

2.37

3.90

1.9

1.3

e6/l

6081.5

79085.6

0.63

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

284

1.81

3.90

3.8

5.3

iu/ml

800.8

214.4

—

(3037121) Protein [Mass/volume] in Urine

490

1.61

3.87

2.8

3.2

g/l

0.2

0.3

0.45

206

(3003338) MCHC [Mass/volume]

1798

17198

1.24

3.85

19.2

12.5

g/l

332.0

332.2

0.27

1789

17072

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.08

3.80

1.1

—

80.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.81

3.80

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1783

17048

1.24

3.78

3.5

3.2

mmol/l

1.3

1.2

4.43

1713

16173

(3026389) Candida sp identified in Specimen by Organism specific culture

280

1.80

3.77

1.4

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

566

1.56

3.74

2.1

1.9

nmol/l

7.9

8.3

0.15

496

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

442

1.63

3.67

1.4

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.48

3.63

3.7

3.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.26

3.62

1.2

1.4

nmol/l

90.7

70.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

156

2.07

3.61

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1150

0.64

3.59

1.4

—

(3000012) Reticulocyte production index

2.76

3.59

1.1

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

130

1783

0.71

3.49

1.4

—

(3022313) Gas panel - Capillary blood

496

1.57

3.48

2.7

3.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.35

3.47

1.2

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

189

1444

1.34

3.45

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

187

1.94

3.44

1.1

u/ml

0.3

3.1

0.89

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

611

1.51

3.42

1.4

1.5

nmol/l

0.4

0.5

0.62

498

(3005033) Fetal Nuchal fold Thickness US

1147

0.65

3.40

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

107

2.26

3.38

1.7

2.6

63.5

53.9

1.70

(3023419) Bacteria identified in Sputum by Culture

120

2.18

3.38

1.9

2.2

—

(3024869) Neuronal Ab [Presence] in Serum

5.73

3.34

1.1

1.0

—

(3011648) Oxygen content in Venous blood

2.33

3.34

2.7

4.5

13.0

11.2

1.39

(4268621)

219

1.84

3.28

2.5

2.3

—

(3011436) Histone Ab [Units/volume] in Serum

3.58

3.19

1.2

1.1

u/ml

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.87

3.19

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

137

2.06

3.17

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

259

1.75

3.15

2.9

2.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

297

1.70

3.13

2.3

2.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.97

3.13

2.6

2.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

414

1.59

3.11

2.4

6.8

1.7

1.6

0.41

384

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

375

1.62

3.11

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.81

3.08

2.4

3.6

—

(3051339) Copper [Moles/volume] in Blood

5.01

3.05

1.6

1.1

umol/l

15.4

16.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

2.51

3.04

1.7

3.3

—

15.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

300

1.68

3.03

1.0

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

126

2.08

3.02

1.1

mg/l

261.2

304.0

2.45

113

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.85

3.02

1.7

1.2

ng/l

83.6

104.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

309

1.67

2.99

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

214

1.79

2.88

1.3

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.68

2.87

1.0

—

(3001729) Color of Synovial fluid

6.68

2.87

2.0

2.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

6.68

2.87

2.0

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

112

813

1.40

2.86

1.3

u/l

11.5

11.0

0.11

661

(3045683) HLA typing for celiac disease panel - Blood or Tissue

164

1.90

2.85

1.0

—

(3008295) Osmolality of Serum or Plasma

136

2.00

2.85

1.2

1.7

mosm/kgh2o

281.8

280.6

0.12

115

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1313

0.70

2.85

1.4

1.5

—

(3015183) Erythrocyte sedimentation rate

150

1.95

2.85

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

159

1222

1.32

2.83

1.6

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.51

2.70

2.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.98

2.69

1.1

1.2

u/ml

0.1

0.0

—

(4306422)

351

1.58

2.66

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

229

1.72

2.60

1.2

1.4

—

(3007463) Buprenorphine [Presence] in Urine

4.68

2.59

2.6

3.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.01

2.56

1.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

149

1.89

2.56

1.3

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.43

2.54

1.0

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

164

1.84

2.53

3.9

4.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.51

2.53

2.3

2.4

umol/l

9.0

16.4

2.66

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

143

1.90

2.51

2.3

1.8

mg/l

20.7

24.0

0.18

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

2.03

2.46

1.4

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

203

1.74

2.45

1.9

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

531

1.45

2.44

2.3

2.9

g/l

3.2

3.5

2.04

502

(3002619) Bacteria identified in Specimen by Culture

2.76

2.37

1.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

125

1.93

2.35

1.6

1.3

umol/l

44.5

64.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.22

2.30

2.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.23

2.27

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.56

2.27

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1294

0.74

2.27

1.4

1.5

—

(3024928) Oxygen saturation in Venous blood

247

1.63

2.25

2.3

3.7

—

(3051611) Lipemic interference index of Serum or Plasma

121

1.91

2.21

3.2

2.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

180

1.73

2.19

1.1

1.0

u/ml

0.1

0.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

2.18

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.51

2.18

2.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.29

2.15

1.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.01

2.14

1.0

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

605

1.39

2.14

2.0

2.4

100.7

95.1

1.59

548

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.01

2.07

1.2

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

4.01

2.04

1.7

2.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

4.01

2.04

4.8

2.5

mg/l

30.5

20.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

1.74

2.02

1.1

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

2.01

2.00

1.2

1.7

nmol/l

130.8

127.1

0.18

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

217

1.62

1.97

4.2

3.7

mg/l

20.6

40.1

0.76

175

(3034860) Kappa light chains.free [Mass/volume] in Serum

217

1.62

1.97

4.2

3.7

mg/l

23.8

54.9

0.92

176

(3006184) Hemoglobin [Mass/volume] in Capillary blood

281

1.54

1.95

2.4

2.2

g/l

132.9

131.1

0.26

215

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.45

1.93

1.0

u/ml

0.1

0.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.45

1.93

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

250

1.57

1.93

3.6

4.4

u/ml

0.3

0.4

0.39

129

(3022689) Creatine [Moles/volume] in Urine

2.57

1.92

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.06

1.91

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

316

1.50

1.89

1.1

iu/ml

21.3

1541.0

0.56

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

157

0.38

1.88

19.8

12.8

nmol/l

859.0

827.1

—

150

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

236

1.58

1.87

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

366

1.46

1.87

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

2.09

1.86

1.3

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.03

1.85

1.1

u/ml

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

122

1.81

1.84

1.3

1.5

nmol/l

2.1

1.5

0.99

109

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.17

1.82

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.58

1.80

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.05

1.80

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

362

1.45

1.77

2.9

3.3

u/ml

96.8

514.6

0.55

305

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.34

1.74

2.0

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.34

1.74

1.5

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

1792

18365

0.87

1.74

15.3

10.6

40.0

39.8

0.94

1470

15091

(40761536) Microorganisms panel - Urine sediment

200

1686

1.20

1.71

4.8

3.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.01

1.69

1.1

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

244

1.53

1.65

1.0

1.1

97.1

95.4

0.14

232

(3024891) Influenza virus A+B Ag [Presence] in Specimen

556

1.34

1.64

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

387

4319

0.87

1.64

1.6

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

158

1.65

1.62

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.58

1.61

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1049

0.76

1.61

1.4

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

174

1.62

1.61

1.8

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.87

1.60

1.1

1.0

u/ml

1.4

2.6

0.39

(44806071)

2.51

1.59

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

375

0.61

1.59

1.6

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

2.01

1.59

1.5

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.00

1.58

1.0

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.11

1.55

1.1

1.4

—

(21494434) Karyotype in Bone marrow

1.93

1.54

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.28

1.53

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

130

1.70

1.53

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.60

1.51

3.0

4.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

521

1.33

1.51

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

234

1.50

1.49

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

127

0.39

1.49

2.8

3.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

385

1.39

1.48

1.3

1.4

mmol/l

6.8

6.9

0.04

277

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

155

1.62

1.47

1.1

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

203

1.53

1.46

1.8

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.37

1.45

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.50

1.45

1.3

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

117

1.72

1.45

1.1

96.5

90.1

0.51

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1668

16219

1.12

1.44

4.2

3.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

188

1.55

1.43

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

423

1.36

1.41

1.6

2.0

g/l

1.2

1.4

0.60

370

(3051651) Icteric interference index of Serum or Plasma

1.86

1.40

3.7

3.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

182

1.55

1.37

2.4

3.7

u/ml

18.5

1578.6

0.62

172

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.95

1.36

1.0

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.95

1.36

1.0

3.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

673

6278

1.10

1.35

1.9

2.0

—

(3017569) Oxygen content in Arterial blood

2.15

1.33

1.6

3.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.15

1.33

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

136

1.62

1.32

1.7

1.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

217

1.48

1.31

1.3

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

121

1.66

1.30

1.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.50

1.30

1.0

u/ml

6.0

6.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.09

1.27

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.09

1.27

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.09

1.27

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

134

0.45

1.27

2.5

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

377

0.66

1.27

4.2

3.6

u/ml

24.7

27.4

0.12

364

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

1.27

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

146

1.58

1.26

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.40

1.24

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.00

1.23

1.6

1.4

ug/l

8.6

8.0

—

(3025577) Chromium [Mass/volume] in Blood

2.00

1.23

2.1

ug/l

1.6

2.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

196

1.49

1.22

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

196

1.49

1.22

1.6

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.17

1.21

1.4

1.5

—

(1002224) Polysomnography panel

112

928

1.22

1.21

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

199

0.55

1.17

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.50

1.15

1.4

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

467

4311

1.11

1.15

1.5

1.6

mmol/l

1.5

1.3

2.16

409

3767

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

100

1206

0.82

1.15

1.7

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

199

1.46

1.14

1.6

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

134

1.57

1.14

1.0

1.1

miu/ml

1974.3

1514.4

0.79

134

(3017509) Phencyclidine [Presence] in Urine

2.34

1.12

1.7

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

135

1.56

1.11

1.2

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.71

1.11

2.1

2.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

124

1049

1.19

1.10

1.8

1.7

mg/l

3.2

3.9

0.53

704

(4094501)

338

1.34

1.08

1.1

—

(3004451) EKG impression Narrative

2.19

1.08

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

194

1.45

1.07

1.6

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

194

1.45

1.07

1.2

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

170

1.48

1.04

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

195

1.44

1.04

1.6

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

246

1.39

1.03

5.2

6.1

umol/l

326.0

378.2

1.54

217

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.28

1.03

1.0

1.2

umol/24h

1.3

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.28

1.03

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

114

1.58

1.02

2.0

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

196

1.43

1.02

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.92

1.02

1.1

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.92

1.02

1.1

2.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.92

1.02

1.1

2.6

—

74685.5

—

(3037756) Immunofixation for Serum or Plasma

147

1.50

1.00

1.5

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.88

1.00

1.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.88

1.00

1.0

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.84

0.98

1.1

3.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.63

0.97

1.8

2.0

—

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

768

1.21

0.97

1.3

—

(1761868) Lipid panel - Serum or Plasma

723

7607

0.93

0.95

2.5

2.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

141

1.49

0.95

1.8

promille

1.9

1.4

0.69

107

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.89

0.94

1.6

3.3

—

45.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.23

0.93

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

2.23

0.93

1.0

8.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

120

0.50

0.93

1.0

1.3

—

(40768793) Breast Pathology biopsy report

563

0.78

0.90

1.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

439

1.26

0.89

1.4

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

194

1.40

0.88

1.0

u/ml

0.3

0.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

941

0.83

0.85

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.76

0.83

1.0

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.70

0.82

1.2

—

66.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.88

0.81

1.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.79

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.67

0.78

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

322

1.28

0.78

2.8

3.4

mg/l

23.6

22.3

0.10

208

(3043410) Blood group antigens tested for on Red Blood Cells

1.70

0.75

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.70

0.75

1.0

1.3

—

(4024509)

149

1.41

0.75

1.3

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.54

0.75

1.0

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

0.72

2.2

2.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.00

0.72

1.0

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

185

1.36

0.72

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.75

0.71

1.3

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

151

1.39

0.71

2.0

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

309

0.74

0.70

2.2

2.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

400

1.23

0.69

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

310

1.26

0.69

1.3

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.56

0.68

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

603

1.18

0.68

1.7

2.3

umol/l

3.7

4.7

1.55

449

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

154

1.37

0.65

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.48

0.64

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.73

0.64

1.0

1.2

—

(3034426) Prothrombin time (PT)

1.52

0.62

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

159

1751

0.90

0.62

3.6

3.4

31.0

32.4

1.03

125

1284

(3045142) Bone marrow Pathology biopsy report

113

1.42

0.61

1.5

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.60

0.0

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.59

0.0

1.3

—

139.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

454

0.81

0.59

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

210

1.29

0.58

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.58

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

453

0.81

0.58

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

311

1.23

0.55

1.4

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.62

0.55

1.0

u/ml

0.0

0.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

107

1.40

0.55

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

107

1.40

0.55

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

107

1.40

0.55

1.3

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

126

0.63

0.54

3.3

7.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

540

5174

1.06

0.54

1.6

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

125

1.36

0.53

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

272

0.77

0.53

1.8

2.7

ug/min

26.4

126.1

2.08

178

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

249

0.76

0.52

1.6

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

317

3355

0.94

0.51

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.43

0.49

1.9

1.5

u/l

1.9

3.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.49

3.7

2.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

681

1.14

0.48

1.1

u/ml

0.8

3.8

—

119

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

277

0.79

0.46

1.1

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.61

0.45

1.4

1.5

g/l

38.4

35.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

166

1.27

0.43

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.38

0.42

1.2

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.52

0.41

1.0

1.4

pmol/l

183.8

368.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.41

0.0

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

161

0.74

0.41

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.36

0.41

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

324

1.18

0.40

1.3

1.6

—

4.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

160

0.75

0.39

1.2

1.4

g/l

0.9

0.25

160

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.38

1.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.38

1.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.38

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.38

1.2

1.6

—

(4035726)

140

1300

1.08

0.38

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

122

1128

1.09

0.37

3.1

3.7

ug/l

3.0

13.1

1.54

825

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.31

0.37

1.3

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

174

1853

0.93

0.37

1.8

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

130

1208

1.08

0.35

1.4

1.3

miu/ml

182.1

236.3

0.94

626

(4133840)

1.43

0.35

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.40

0.35

2.3

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

341

0.85

0.35

2.1

2.3

ug/l

0.9

0.7

0.22

168

(3003694) ABO and Rh group [Type] in Blood

659

6416

1.04

0.34

1.6

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

625

0.89

0.33

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

100

1.30

0.33

1.5

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

397

1.14

0.33

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.28

0.32

3.8

2.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

598

1.11

0.32

4.0

3.4

ug/l

1.9

2.0

0.06

544

(4281824)

208

0.82

0.31

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

193

1.19

0.30

1.4

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

533

1.11

0.30

7.0

10.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

102

1.28

0.30

1.6

2.0

u/field

1.5

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

172

1631

1.06

0.29

6.5

4.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

678

0.91

0.27

1.2

1.3

ug/l

2.4

4.1

2.91

633

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.25

0.27

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

461

1.11

0.27

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.21

0.26

1.3

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.70

0.26

1.4

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

397

1.11

0.25

1.0

1.1

u/ml

1.1

2.8

1.99

223

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.71

0.24

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

u/ml

0.1

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.25

0.22

1.0

1.1

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.3

—

72.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

3.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.9

—

(4146454)

1.23

0.21

2.0

2.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.16

0.21

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

117

1.20

0.20

1.1

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

240

1.13

0.20

2.0

4.6

u/ml

24.0

83.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.20

0.19

2.7

2.0

—

151.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

127

1.18

0.19

1.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.13

0.18

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

143

0.84

0.18

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

1.19

0.18

1.3

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

119

1.18

0.17

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.13

0.17

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.11

0.17

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

214

0.89

0.15

1.0

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.75

0.15

1.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

657

0.94

0.15

1.8

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

390

1.08

0.15

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

399

0.93

0.14

1.6

mmol/l

7.2

7.5

0.47

247

(4211845)

0.82

0.13

1.4

2.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

109

0.82

0.13

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

110

0.82

0.13

1.0

1.1

—

(44790049)

163

1.11

0.10

1.3

—

(44790047)

163

1.11

0.10

1.3

—

(44806118)

163

1.11

0.10

1.3

—

(44790048)

163

1.11

0.10

1.3

—

(3025130) Human papilloma virus identified in Specimen

516

1.05

0.09

1.7

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

279

2746

1.02

0.09

1.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

1.3

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

1.3

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.11

0.09

1.3

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.09

0.09

1.2

3.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.81

0.08

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.81

0.07

1.0

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.89

0.06

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

110

0.91

0.05

2.7

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

120

0.92

0.05

1.0

1.1

—

(40768441) Liver Pathology biopsy report

120

1.08

0.05

1.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

378

1.03

0.04

2.6

7.5

mmol/l

1.1

0.02

329

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

462

0.97

0.03

4.1

3.3

20.5

22.5

0.51

159

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

149

0.94

0.03

1.6

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

580

5776

1.01

0.03

1.6

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

176

0.97

0.00

1.5

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

145

0.97

0.00

1.6

1.4

—

(40768795) Lymph node Pathology biopsy report

153

0.98

0.00

1.5

1.2

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

36.4

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.3

—

7.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.3

—

2.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

6.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

34.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

7.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.96

0.00

1.0

ug/l

103.2

74.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(3006462) Nitrate [Presence] in Urine

0.95

0.00

1.4

2.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.4

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

29.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.90

0.00

4.6

2.2

nmol/l

97.7

155.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.00

0.0

1.3

—

74.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.90

0.00

1.3

1.6

—

(4038314)

0.00

0.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.2

—

609.2

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

20.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

5.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_HYPERMOBILITY and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_HYPERMOBILITY	0.823 [0.69, 0.99]	0.036
Birth year	0.995 [0.99, 1.0]	0.279

During the follow-up period (1.1.1998 — 31.12.2019), 192 out of 10095 females with M13_HYPERMOBILITY died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_HYPERMOBILITY.

N-year risk	Females	Males
1	0.072%	No data
5	0.416%	No data
10	1.087%	No data
15	2.289%	No data
20	4.021%	No data

Relationships between endpoints

↥

Index endpoint: M13_HYPERMOBILITY – Hypermobility syndrome

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypermobility syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints